MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, intended to be added as a commercial feature to the company's Edge AI Intoxication Detection Kiosks. The expansion of the company's voice-based diagnostics platform aims to identify both intoxication and neurological impairment, with initial commercial testing of the kiosk platform expected in late second quarter 2026.
The fatigue detection module is designed for high-risk industries including aviation, road transport, and mining. By leveraging the same underlying voice analysis technology used to detect alcohol intoxication, the new module can identify signs of fatigue, which is a critical safety concern in these sectors. The company's AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. This same approach is being applied to fatigue detection.
MindBio is a biotechnology company that is commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction, and law enforcement.
According to the company, the addition of fatigue detection technology represents a significant step forward in workplace safety. Fatigue is a leading cause of accidents in high-risk industries, and the ability to detect it non-invasively through voice analysis could provide a valuable tool for employers. The kiosks are designed to be deployed in entry points or common areas, allowing for quick and accurate screening.
The announcement underscores the growing interest in AI-driven voice analysis for health and safety applications. With the initial commercial testing slated for late second quarter 2026, MindBio is positioning itself at the forefront of this emerging field. The company's technology has already demonstrated high accuracy in detecting alcohol intoxication, and the extension to fatigue detection could open up new markets and applications.
For more information, visit the company's newsroom at https://nnw.fm/MBQIF. The full press release is available at https://nnw.fm/WWgcb.
